﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2024v5.2">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2025-11-10T15:07:19-06:00</ReturnTs>
    <TaxPeriodEndDt>2024-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>042387531</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>SULLIVAN &amp; WORCESTER</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>ONE POST OFFICE SQUARE</AddressLine1Txt>
        <CityNm>BOSTON</CityNm>
        <StateAbbreviationCd>MA</StateAbbreviationCd>
        <ZIPCd>02109</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2024-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>043528004</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>POPPLESTONE FOUNDATION</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>C/O SULLIVAN &amp; WORCESTER LLP</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>POPP</BusinessNameControlTxt>
      <PhoneNum>6173382839</PhoneNum>
      <USAddress>
        <AddressLine1Txt>ONE POST OFFICE SQUARE</AddressLine1Txt>
        <CityNm>BOSTON</CityNm>
        <StateAbbreviationCd>MA</StateAbbreviationCd>
        <ZIPCd>02109</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>SALLY L RUBIN</PersonNm>
      <PersonTitleTxt>TRUSTEE</PersonTitleTxt>
      <PhoneNum>6173382839</PhoneNum>
      <SignatureDt>2025-11-10</SignatureDt>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>0</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>CHRISTOPHER C CURTIS</PreparerPersonNm>
      <PTIN>P00492268</PTIN>
      <PhoneNum>6173382800</PhoneNum>
      <SelfEmployedInd>X</SelfEmployedInd>
    </PreparerPersonGrp>
    <TaxYr>2024</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="12">
    <IRS990PF documentId="RetDoc1235000001">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>18463724</FMVAssetsEOYAmt>
      <MethodOfAccountingCashInd>X</MethodOfAccountingCashInd>
      <AnalysisOfRevenueAndExpenses>
        <ContriRcvdRevAndExpnssAmt>6897404</ContriRcvdRevAndExpnssAmt>
        <DividendsRevAndExpnssAmt>1545880</DividendsRevAndExpnssAmt>
        <DividendsNetInvstIncmAmt>1545880</DividendsNetInvstIncmAmt>
        <NetGainSaleAstRevAndExpnssAmt>-7275255</NetGainSaleAstRevAndExpnssAmt>
        <GrossSalesPriceAmt>2572341</GrossSalesPriceAmt>
        <CapGainNetIncmNetInvstIncmAmt>0</CapGainNetIncmNetInvstIncmAmt>
        <OtherIncomeRevAndExpnssAmt referenceDocumentId="RetDoc2001500001">28544</OtherIncomeRevAndExpnssAmt>
        <OtherIncomeNetInvstIncmAmt>28544</OtherIncomeNetInvstIncmAmt>
        <TotalRevAndExpnssAmt>1196573</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>1574424</TotalNetInvstIncmAmt>
        <CompOfcrDirTrstRevAndExpnssAmt>0</CompOfcrDirTrstRevAndExpnssAmt>
        <CompOfcrDirTrstNetInvstIncmAmt>0</CompOfcrDirTrstNetInvstIncmAmt>
        <CompOfcrDirTrstDsbrsChrtblAmt>0</CompOfcrDirTrstDsbrsChrtblAmt>
        <LegalFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002100001">35227</LegalFeesRevAndExpnssAmt>
        <LegalFeesNetInvstIncmAmt>0</LegalFeesNetInvstIncmAmt>
        <LegalFeesDsbrsChrtblAmt>35227</LegalFeesDsbrsChrtblAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="RetDoc2002500001">75200</TaxesRevAndExpnssAmt>
        <TaxesNetInvstIncmAmt>0</TaxesNetInvstIncmAmt>
        <TaxesDsbrsChrtblAmt>0</TaxesDsbrsChrtblAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="RetDoc2003200001">399301</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesNetInvstIncmAmt>133268</OtherExpensesNetInvstIncmAmt>
        <OtherExpensesDsbrsChrtblAmt>266033</OtherExpensesDsbrsChrtblAmt>
        <TotOprExpensesRevAndExpnssAmt>509728</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>133268</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>301260</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>51278754</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>51278754</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>51788482</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>133268</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>51580014</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>-50591909</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>1441156</NetInvestmentIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <SavAndTempCashInvstBOYAmt>21533777</SavAndTempCashInvstBOYAmt>
        <SavAndTempCashInvstEOYAmt>362853</SavAndTempCashInvstEOYAmt>
        <SavAndTempCashInvstEOYFMVAmt>362853</SavAndTempCashInvstEOYFMVAmt>
        <USGovernmentObligationsBOYAmt>45802343</USGovernmentObligationsBOYAmt>
        <USGovernmentObligationsEOYAmt referenceDocumentId="RetDoc2210400001">26237155</USGovernmentObligationsEOYAmt>
        <USGovtObligationsEOYFMVAmt>17128320</USGovtObligationsEOYFMVAmt>
        <CorporateStockBOYAmt>9795943</CorporateStockBOYAmt>
        <CorporateStockEOYAmt>0</CorporateStockEOYAmt>
        <CorporateStockEOYFMVAmt>0</CorporateStockEOYFMVAmt>
        <OtherInvestmentsBOYAmt>1032406</OtherInvestmentsBOYAmt>
        <OtherInvestmentsEOYAmt referenceDocumentId="RetDoc2018100001">972551</OtherInvestmentsEOYAmt>
        <OtherInvestmentsEOYFMVAmt>972551</OtherInvestmentsEOYFMVAmt>
        <TotalAssetsBOYAmt>78164469</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>27572559</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>18463724</TotalAssetsEOYFMVAmt>
        <TotalLiabilitiesBOYAmt>0</TotalLiabilitiesBOYAmt>
        <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
        <OrgDoesNotFollowFASB117Ind>X</OrgDoesNotFollowFASB117Ind>
        <CapitalStockBOYAmt>0</CapitalStockBOYAmt>
        <CapitalStockEOYAmt>0</CapitalStockEOYAmt>
        <AdditionalPaidInCapitalBOYAmt>0</AdditionalPaidInCapitalBOYAmt>
        <AdditionalPaidInCapitalEOYAmt>0</AdditionalPaidInCapitalEOYAmt>
        <RetainedEarningBOYAmt>78164469</RetainedEarningBOYAmt>
        <RetainedEarningEOYAmt>27572559</RetainedEarningEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>78164469</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>27572559</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>78164469</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>27572559</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>78164469</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>-50591909</ExcessRevenueOverExpensesAmt>
        <OtherIncreasesAmt>0</OtherIncreasesAmt>
        <SubtotalAmt>27572560</SubtotalAmt>
        <OtherDecreasesAmt referenceDocumentId="RetDoc2049800001">1</OtherDecreasesAmt>
        <TotNetAstOrFundBalancesEOYAmt>27572559</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <CapGainsLossTxInvstIncmDetail>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>15,728 SHS. ENANTA PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2021-01-19</AcquiredDt>
          <SoldDt>2024-06-06</SoldDt>
          <GrossSalesPriceAmt>204957</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>758247</CostOrOtherBasisAmt>
          <GainOrLossAmt>-553290</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-553290</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>10,467 SHS. ENANTA PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2021-01-19</AcquiredDt>
          <SoldDt>2024-06-07</SoldDt>
          <GrossSalesPriceAmt>130428</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>504614</CostOrOtherBasisAmt>
          <GainOrLossAmt>-374186</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-374186</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>23,805 SHS. ENANTA PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2021-01-19</AcquiredDt>
          <SoldDt>2024-06-08</SoldDt>
          <GrossSalesPriceAmt>311104</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1147639</CostOrOtherBasisAmt>
          <GainOrLossAmt>-836535</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-836535</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>6,145 SHS. ENANTA PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2021-01-19</AcquiredDt>
          <SoldDt>2024-08-16</SoldDt>
          <GrossSalesPriceAmt>74994</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>296250</CostOrOtherBasisAmt>
          <GainOrLossAmt>-221256</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-221256</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>22,903 SHS. ENANTA PHARMACEUTICALS</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2021-01-19</AcquiredDt>
          <SoldDt>2024-08-19</SoldDt>
          <GrossSalesPriceAmt>285306</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1104154</CostOrOtherBasisAmt>
          <GainOrLossAmt>-818848</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-818848</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>12,100 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2021-01-19</AcquiredDt>
          <SoldDt>2024-08-20</SoldDt>
          <GrossSalesPriceAmt>151510</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>583341</CostOrOtherBasisAmt>
          <GainOrLossAmt>-431831</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-431831</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>8,852 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2021-01-19</AcquiredDt>
          <SoldDt>2024-08-21</SoldDt>
          <GrossSalesPriceAmt>109599</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>421468</CostOrOtherBasisAmt>
          <GainOrLossAmt>-311869</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-311869</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>4,114 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-12-10</AcquiredDt>
          <SoldDt>2024-09-24</SoldDt>
          <GrossSalesPriceAmt>44766</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>194355</CostOrOtherBasisAmt>
          <GainOrLossAmt>-149589</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-149589</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>12,268 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-12-10</AcquiredDt>
          <SoldDt>2024-09-25</SoldDt>
          <GrossSalesPriceAmt>134132</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>579570</CostOrOtherBasisAmt>
          <GainOrLossAmt>-445438</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-445438</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>8,618 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-12-10</AcquiredDt>
          <SoldDt>2024-09-27</SoldDt>
          <GrossSalesPriceAmt>88511</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>406612</CostOrOtherBasisAmt>
          <GainOrLossAmt>-318101</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-318101</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>15,439 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-12-10</AcquiredDt>
          <SoldDt>2024-10-03</SoldDt>
          <GrossSalesPriceAmt>172768</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>710692</CostOrOtherBasisAmt>
          <GainOrLossAmt>-537924</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-537924</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>9,561 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-10-23</AcquiredDt>
          <SoldDt>2024-10-04</SoldDt>
          <GrossSalesPriceAmt>106600</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>427508</CostOrOtherBasisAmt>
          <GainOrLossAmt>-320908</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-320908</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>10,536 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-10-23</AcquiredDt>
          <SoldDt>2024-10-11</SoldDt>
          <GrossSalesPriceAmt>115686</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>449367</CostOrOtherBasisAmt>
          <GainOrLossAmt>-333681</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-333681</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>14,255 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-09-12</AcquiredDt>
          <SoldDt>2024-10-14</SoldDt>
          <GrossSalesPriceAmt>161049</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>585752</CostOrOtherBasisAmt>
          <GainOrLossAmt>-424703</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-424703</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>5,209 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-09-12</AcquiredDt>
          <SoldDt>2024-10-15</SoldDt>
          <GrossSalesPriceAmt>58853</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>213232</CostOrOtherBasisAmt>
          <GainOrLossAmt>-154379</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-154379</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>3,145 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-04-02</AcquiredDt>
          <SoldDt>2024-10-25</SoldDt>
          <GrossSalesPriceAmt>37712</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>123737</CostOrOtherBasisAmt>
          <GainOrLossAmt>-86025</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-86025</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>9,805 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-04-02</AcquiredDt>
          <SoldDt>2024-10-28</SoldDt>
          <GrossSalesPriceAmt>114701</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>384249</CostOrOtherBasisAmt>
          <GainOrLossAmt>-269548</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-269548</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>4,575 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-03-04</AcquiredDt>
          <SoldDt>2024-10-29</SoldDt>
          <GrossSalesPriceAmt>51924</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>177963</CostOrOtherBasisAmt>
          <GainOrLossAmt>-126039</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-126039</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>5,588 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-03-04</AcquiredDt>
          <SoldDt>2024-11-08</SoldDt>
          <GrossSalesPriceAmt>62253</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>214791</CostOrOtherBasisAmt>
          <GainOrLossAmt>-152538</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-152538</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>3,786 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-02-14</AcquiredDt>
          <SoldDt>2024-11-11</SoldDt>
          <GrossSalesPriceAmt>41269</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>144545</CostOrOtherBasisAmt>
          <GainOrLossAmt>-103276</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-103276</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>10,626 SHS. ENANTA PHARMACEUTICAL</PropertyDesc>
          <HowAcquiredCd>D</HowAcquiredCd>
          <AcquiredDt>2014-02-14</AcquiredDt>
          <SoldDt>2024-11-12</SoldDt>
          <GrossSalesPriceAmt>114219</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>367856</CostOrOtherBasisAmt>
          <GainOrLossAmt>-253637</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-253637</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>K-1 LINE 9A BIOVENTURES INVESTORS LIMITED PARTNERSHIP II</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <CostOrOtherBasisAmt>51654</CostOrOtherBasisAmt>
          <GainOrLossAmt>-51654</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-51654</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapitalGainNetIncomeAmt>-7275255</CapitalGainNetIncomeAmt>
      </CapGainsLossTxInvstIncmDetail>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>20032</InvestmentIncomeExciseTaxAmt>
        <TaxUnderSection511Amt>0</TaxUnderSection511Amt>
        <SubtotalAmt>20032</SubtotalAmt>
        <SubtitleATaxAmt>0</SubtitleATaxAmt>
        <TaxBasedOnInvestmentIncomeAmt>20032</TaxBasedOnInvestmentIncomeAmt>
        <EstimatedPlusOvpmtIncmTxAmt>35025</EstimatedPlusOvpmtIncmTxAmt>
        <ExemptFrgnOrgTaxWthldAtSrceAmt>0</ExemptFrgnOrgTaxWthldAtSrceAmt>
        <ExtsnRequestIncomeTaxPaidAmt>0</ExtsnRequestIncomeTaxPaidAmt>
        <BackupWithholdingWithheldAmt>0</BackupWithholdingWithheldAmt>
        <TotalPaymentsAndCreditsAmt>35025</TotalPaymentsAndCreditsAmt>
        <Form2220AttachedInd referenceDocumentId="RetDoc1192000001">X</Form2220AttachedInd>
        <EsPenaltyAmt>0</EsPenaltyAmt>
        <OverpaymentAmt>14993</OverpaymentAmt>
        <AppliedToESTaxAmt>14993</AppliedToESTaxAmt>
        <RefundAmt>0</RefundAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>0</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>0</MoreThan100SpentInd>
        <Form1120POLFiledInd>0</Form1120POLFiledInd>
        <Section4955OrganizationTaxAmt>0</Section4955OrganizationTaxAmt>
        <Section4955ManagersTaxAmt>0</Section4955ManagersTaxAmt>
        <TaxReimbursedAmt>0</TaxReimbursedAmt>
        <ActivitiesNotPreviouslyRptInd>0</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>0</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>1</UnrelatedBusIncmOverLimitInd>
        <Form990TFiledInd>1</Form990TFiledInd>
        <OrganizationDissolvedEtcInd referenceDocumentId="RetDoc2138700001 RetDoc2210900001">1</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>1</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>1</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>MA</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>1</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>0</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd referenceDocumentId="RetDoc2089200001">1</NewSubstantialContributorsInd>
        <OwnControlledEntityInd>0</OwnControlledEntityInd>
        <DonorAdvisedFundInd referenceDocumentId="RetDoc2330900001">1</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>1</ComplyWithPublicInspRqrInd>
        <WebsiteAddressTxt>N/A</WebsiteAddressTxt>
        <IndividualWithBooksNm>CHRISTOPHER C CURTIS ESQ</IndividualWithBooksNm>
        <PhoneNum>6173382800</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>SULLIVAN WORCESTER LLP 1 POST</AddressLine1Txt>
          <AddressLine2Txt>OFFICE SQUARE</AddressLine2Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02109</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>0</ForeignAccountsQuestionInd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>0</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>0</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>0</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>0</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>0</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>0</PaymentToGovernmentOfficialInd>
        <UncorrectedPriorActsInd>0</UncorrectedPriorActsInd>
        <UndistributedIncomePYInd>0</UndistributedIncomePYInd>
        <BusinessHoldingsInd>0</BusinessHoldingsInd>
        <JeopardyInvestmentsInd>0</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>0</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>0</InfluenceLegislationInd>
        <InfluenceElectionInd>0</InfluenceElectionInd>
        <GrantsToIndividualsInd>0</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>0</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>0</NoncharitablePurposeInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
        <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>SUZANNE E WERBER DWORSKY DECEASED</PersonNm>
          <USAddress>
            <AddressLine1Txt>8 MERCER CIRCLE</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02138</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>0.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>SALLY L RUBIN</PersonNm>
          <USAddress>
            <AddressLine1Txt>83 KIRKSTALL ROAD</AddressLine1Txt>
            <CityNm>NEWTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02460</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>0.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompOfHghstPdEmplOrNONETxt>NONE</CompOfHghstPdEmplOrNONETxt>
        <OtherEmployeePaidOver50kCnt>0</OtherEmployeePaidOver50kCnt>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>ROCKEFELLER PHILANTHROPY ADVISORS</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>120 BROADWAY SUITE 3475</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10271</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>CONSULTING FOR PRIVATE FOUNDATION MANAGEMENT</ServiceTypeTxt>
          <CompensationAmt>262059</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>NORTHERN TRUST COMPANY</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>125 SUMMER STREET STE 1400</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02110</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>INVESTMENT CUSTODY AND MANAGEMENT</ServiceTypeTxt>
          <CompensationAmt>96523</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>SULLIVAN &amp; WORCESTER LLP</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>ONE POST OFFICE SQUARE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02109</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>LEGAL &amp; ACCOUNTING</ServiceTypeTxt>
          <CompensationAmt>35227</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <CompensationOfHghstPdCntrctGrp>
          <BusinessName>
            <BusinessNameLine1Txt>GMA FOUNDATIONS</BusinessNameLine1Txt>
          </BusinessName>
          <USAddress>
            <AddressLine1Txt>2 LIBERTY SQUARE STE 500</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02109</ZIPCd>
          </USAddress>
          <ServiceTypeTxt>CONSULTING FOR PRIVATE FOUNDATION MANAGEMENT</ServiceTypeTxt>
          <CompensationAmt>1974</CompensationAmt>
        </CompensationOfHghstPdCntrctGrp>
        <ContractorPaidOver50kCnt>0</ContractorPaidOver50kCnt>
      </OfficerDirTrstKeyEmplInfoGrp>
      <SumOfProgramRelatedInvstGrp>
        <TotalAmt>0</TotalAmt>
      </SumOfProgramRelatedInvstGrp>
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>22380458</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>11344938</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>0</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>33725396</TotalFMVOfUnusedAssetsAmt>
        <ReductionClaimedAmt>0</ReductionClaimedAmt>
        <AcquisitionIndebtednessAmt>0</AcquisitionIndebtednessAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>33725396</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>505881</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>33219515</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>1660976</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <MinimumInvestmentReturnAmt>1660976</MinimumInvestmentReturnAmt>
        <TaxBasedOnInvestmentIncomeAmt>20032</TaxBasedOnInvestmentIncomeAmt>
        <TotalTaxAmt>20032</TotalTaxAmt>
        <DistributableBeforeAdjAmt>1640944</DistributableBeforeAdjAmt>
        <RecoveriesQualfiedDistriAmt>0</RecoveriesQualfiedDistriAmt>
        <DistributableBeforeDedAmt>1640944</DistributableBeforeDedAmt>
        <DeductionFromDistributableAmt>0</DeductionFromDistributableAmt>
        <DistributableAsAdjustedAmt>1640944</DistributableAsAdjustedAmt>
      </DistributableAmountGrp>
      <PFQualifyingDistributionsGrp>
        <ExpensesAndContributionsAmt>51580014</ExpensesAndContributionsAmt>
        <ProgramRelatedInvstTotalAmt>0</ProgramRelatedInvstTotalAmt>
        <QualifyingDistributionsAmt>51580014</QualifyingDistributionsAmt>
      </PFQualifyingDistributionsGrp>
      <UndistributedIncomeGrp>
        <DistributableAsAdjustedAmt>1640944</DistributableAsAdjustedAmt>
        <UndistributedIncomePYAmt>0</UndistributedIncomePYAmt>
        <TotalForPriorYearsAmt>0</TotalForPriorYearsAmt>
        <ExcessDistributionCyovYr4Amt>16278584</ExcessDistributionCyovYr4Amt>
        <ExcessDistributionCyovYr3Amt>4124029</ExcessDistributionCyovYr3Amt>
        <ExcessDistributionCyovYr2Amt>22216213</ExcessDistributionCyovYr2Amt>
        <ExcessDistributionCyovYr1Amt>139434676</ExcessDistributionCyovYr1Amt>
        <TotalExcessDistributionCyovAmt>182053502</TotalExcessDistributionCyovAmt>
        <QualifyingDistributionsAmt>51580014</QualifyingDistributionsAmt>
        <AppliedToYear1Amt>0</AppliedToYear1Amt>
        <AppliedToPriorYearsAmt>0</AppliedToPriorYearsAmt>
        <TreatedAsDistriFromCorpusAmt>0</TreatedAsDistriFromCorpusAmt>
        <AppliedToCurrentYearAmt>1640944</AppliedToCurrentYearAmt>
        <RemainingDistriFromCorpusAmt>49939070</RemainingDistriFromCorpusAmt>
        <ExcessDistriCyovAppCYCorpusAmt>0</ExcessDistriCyovAppCYCorpusAmt>
        <ExcessDistributionCyovAppCYAmt>0</ExcessDistributionCyovAppCYAmt>
        <TotalCorpusAmt>231992572</TotalCorpusAmt>
        <PriorYearUndistributedIncmAmt>0</PriorYearUndistributedIncmAmt>
        <PriorYearDeficiencyOrTaxAmt>0</PriorYearDeficiencyOrTaxAmt>
        <Taxable1Amt>0</Taxable1Amt>
        <Taxable2Amt>0</Taxable2Amt>
        <UndistributedIncomeCYAmt>0</UndistributedIncomeCYAmt>
        <CorpusDistri170b1EOr4942g3Amt>0</CorpusDistri170b1EOr4942g3Amt>
        <ExcessDistriCyovFromYr5Amt>0</ExcessDistriCyovFromYr5Amt>
        <ExcessDistriCyovToNextYrAmt>231992572</ExcessDistriCyovToNextYrAmt>
        <ExcessFromYear4Amt>16278584</ExcessFromYear4Amt>
        <ExcessFromYear3Amt>4124029</ExcessFromYear3Amt>
        <ExcessFromYear2Amt>22216213</ExcessFromYear2Amt>
        <ExcessFromYear1Amt>139434676</ExcessFromYear1Amt>
        <ExcessFromCurrentYearAmt>49939070</ExcessFromCurrentYearAmt>
      </UndistributedIncomeGrp>
      <SupplementaryInformationGrp>
        <OnlyContriToPreselectedInd>X</OnlyContriToPreselectedInd>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>AMERICAN JOURNALISM PROJECT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>6218 GEORGIA AVE NW STE 1-599</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20011</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - GENERAL OPERATIONS</GrantOrContributionPurposeTxt>
          <Amt>825000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>BOSTON DEBATE LEAGUE</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1542 TREMONT ST</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02120</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - SUPPORT "ADVANCING ACHIEVEMENT &amp; IMPACT"</GrantOrContributionPurposeTxt>
          <Amt>325000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CAMBRIDGE PUBLIC SCHOOLS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>159 THORNDIKE STREET</AddressLine1Txt>
            <CityNm>CAMBRIDGE</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02141</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MUSIC EDUCATION - MUSIC DEPARTMENT INITIATIVES - KODALY PROGRAM &amp; MUSIC ACADEMIC YEAR 2023-2024</GrantOrContributionPurposeTxt>
          <Amt>303754</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>CAMPAIGN LEGAL CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1101 14TH ST NW STE 400</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - COMBATING ELECTION SABOTAGE</GrantOrContributionPurposeTxt>
          <Amt>3250000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>EDVESTORS INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>200 NEWBURY STREET</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02116</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MUSIC EDUCATION - SUPPORT MUSIC PROGRAM OF BOSTON PUBLIC SCHOOLS ARTS EXPANSION</GrantOrContributionPurposeTxt>
          <Amt>550000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FAIR ELECTIONS CENTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1825 K ST NW STE 450</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20006</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - CAMPUS VOTE PROJECT</GrantOrContributionPurposeTxt>
          <Amt>650000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>FIDELITY CHARITABLE GIFT FUND</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 770001</AddressLine1Txt>
            <CityNm>CINCINNATI</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>45277</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>OTHER PHILANTHROPIC ENDEAVORS</GrantOrContributionPurposeTxt>
          <Amt>150000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>GENERATION CITIZEN</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>110 WALL ST 5TH FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10005</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - HANDS-ON CIVICS EDUCATION</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>HARMONY PROGRAM</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>244-250 WEST 54TH ST STE 300</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10019</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MUSIC EDUCATION - PROJECT SUPPORT FOR DEVELOPMENT OF A COMPREHENSIVE YOUTH ORCHESTRA SYSTEM NYC FOR 03/25/2024-07/14/2026</GrantOrContributionPurposeTxt>
          <Amt>2000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>KEYS MUSIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2200 NORTH AVENUE</AddressLine1Txt>
            <CityNm>BRIDGEPORT</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06604</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MUSIC EDUCATION - GENERAL SUPPORT PROVIDING FREE MUSIC EDUCATION FOR VOICE &amp; INSTRUMENTS K-12 IN PUBLIC SCHOOLS</GrantOrContributionPurposeTxt>
          <Amt>300000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MASSACHUSETTS BUDGET AND POLICY CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>ONE STATE ST STE 1250</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02109</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - SUPPORT "DELIVERING ON EQUITY COLLECTIVE"</GrantOrContributionPurposeTxt>
          <Amt>325000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW ENGLAND CONSERVATORY OF MUSIC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>290 HUNTINGTON AVENUE</AddressLine1Txt>
            <CityNm>BOSTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>02115</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MUSIC EDUCATION - SUPPORT NEC PREPARATORY DIVISION'S EARLY CHILDHOOD EDUCATION PILOT PROJECT</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>NEW VENTURE FUND FBO MEDIA DEMOCRACY FUND</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1828 L STREET NW 300-A</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20036</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - SUPPORT MEDIA DEMOCRACY FUND'S DISINFORMATION DEFENSE LEAGUE</GrantOrContributionPurposeTxt>
          <Amt>600000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>OPEN SECRETS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>300 L STREET NW SUITE 200</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - SUPPORT FOR "UP FOR DEBATE: ISSUES, CONTROVERSIES &amp; MONEY"</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PARENTCHILD INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>242 W 30TH STREET 1000</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10001</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EARLY CHILDHOOD DEVELOPMENT - EXPANSION OF EXISTING SITES &amp; NEW SITES</GrantOrContributionPurposeTxt>
          <Amt>500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PARENTCORPS</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>180 MADISON AVENUE FLOOR 2</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10016</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EARLY CHILDHOOD DEVELOPMENT - GENERAL OPERATING SUPPORT, EXPANSION OF PRE-K FOR ALL FOR 03/15/2024-08/14/2026</GrantOrContributionPurposeTxt>
          <Amt>3000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PRO PUBLICA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>155 AVENUE OF THE AMERICAS 13TH FL</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10013</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - GENERAL OPERATING SUPPORT, FIVE-YEAR PLAN - INVESTIGATIVE REPORTING FOR 03/15/2024-03/05/2029</GrantOrContributionPurposeTxt>
          <Amt>2500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>PROTECT DEMOCRACY PROJECT</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>2020 PENNSYLVANIA AVE NW 163</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20006</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - GENERAL OPERATING SUPPORT, SAFEBUARDING ELECTIONS &amp; LEGAL ACCOUNTABILITY FOR 03/15/2024-03/15/2026</GrantOrContributionPurposeTxt>
          <Amt>10000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>SD FOUNDATION FBO VOTING RIGHTS LAB</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>611 PENNSYLVANIA AVE SE 201</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20003</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - GENERAL OPERATING SUPPORT, SUPPORTING GENERAL ELECTION OFFICIALS IN 2024 ELECTION FOR 03/13/2024-03/31/2025</GrantOrContributionPurposeTxt>
          <Amt>2500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>STATES UNITED DEMOCRACY CENTER INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>1101 17TH ST SUITE 250</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20036</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - GENERAL OPERATING SUPPORT, SAFEBUARDING ELECTIONS &amp; LEGAL ACCOUNTABILITY FOR 03/15/2024-03/15/2026</GrantOrContributionPurposeTxt>
          <Amt>5000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>THE READING LEAGUE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>103 WYOMING ST 2ND FLOOR</AddressLine1Txt>
            <CityNm>SYRACUSE</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>13204</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>EARLY CHILDHOOD DEVELOPMENT - GENERAL OPERATING SUPPORT, FURTHER THE SCIENCE OF READING MOVEMENT FOR 03/15/2024-03/15/2026</GrantOrContributionPurposeTxt>
          <Amt>2500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>TIDES FOUNDATION FBO MOVEMENT VOTER FUND</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>37 BRIDGE ST BOX 749</AddressLine1Txt>
            <CityNm>NORTHAMPTON</CityNm>
            <StateAbbreviationCd>MA</StateAbbreviationCd>
            <ZIPCd>01060</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - MOVEMENT VOTER FUND: EXPANDING DEMOCRACY THROUGH CIVIC ENGAGEMENT</GrantOrContributionPurposeTxt>
          <Amt>1500000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>WILLIAM J BRENNAN JR CENTER FOR JUSTICE INC</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>120 BROADWAY SUITE 1750</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10271</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>DEMOCRACY &amp; CIVIC ENGAGEMENT - ADVANCE PROJECTS FOCUSING ON STATE &amp; FEDERAL COURTS AND CONSTITUTIONS</GrantOrContributionPurposeTxt>
          <Amt>10000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>YOUNG PEOPLE'S CHORUS OF NEW YORK CITY</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>37 WEST 65TH ST 2ND FL</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10023</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>PUBLIC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MUSIC EDUCATION - GENERAL SUPPORT, SERVING AGES 8-18 IN VARIOUS CHORUSES FOR 03/15/2024-09/15/2027</GrantOrContributionPurposeTxt>
          <Amt>3000000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <TotalGrantOrContriPdDurYrAmt>51278754</TotalGrantOrContriPdDurYrAmt>
        <TotalGrantOrContriApprvFutAmt>0</TotalGrantOrContriApprvFutAmt>
      </SupplementaryInformationGrp>
      <AnalysisIncomeProducingActyGrp>
        <DividendsAndInterestFromSecDtl>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>1545880</ExclusionAmt>
        </DividendsAndInterestFromSecDtl>
        <OtherInvestmentIncomeGrp>
          <BusinessCd>541700</BusinessCd>
          <UnrelatedBusinessTaxblIncmAmt>28544</UnrelatedBusinessTaxblIncmAmt>
        </OtherInvestmentIncomeGrp>
        <GainSalesAstOthThanInvntryGrp>
          <ExclusionCd>18</ExclusionCd>
          <ExclusionAmt>-7275255</ExclusionAmt>
        </GainSalesAstOthThanInvntryGrp>
        <SubtotalsIncmProducingActyGrp>
          <UnrelatedBusinessTaxblIncmAmt>28544</UnrelatedBusinessTaxblIncmAmt>
          <ExclusionAmt>-5729375</ExclusionAmt>
          <RelatedOrExemptFunctionIncmAmt>0</RelatedOrExemptFunctionIncmAmt>
        </SubtotalsIncmProducingActyGrp>
        <TotalIncomeProducingActyAmt>-5700831</TotalIncomeProducingActyAmt>
      </AnalysisIncomeProducingActyGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>0</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>0</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>0</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>0</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>0</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>0</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>0</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>0</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>0</SharingOfFacilitiesEtcInd>
        <RelationshipsNonchrtblEOInd>0</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <GeneralRuleInd>X</GeneralRuleInd>
      <ContributorInformationGrp>
        <ContributorNum>1</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1Txt>ALAN J DWORSKY IRREVOCABLE TRUST</BusinessNameLine1Txt>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1Txt>8 MERCER CIRCLE</AddressLine1Txt>
          <CityNm>CAMBRIDGE</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02138</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>6897404</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <DissolutionStmt documentId="RetDoc2138700001">
      <DissolutionInformationGrp>
        <BusinessName>
          <BusinessNameLine1Txt>SEE THE CHARITABLE RECIPIENTS ON FORM 990-PF PART XIV</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>C/O ONE POST OFFICE SQUARE</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02109</ZIPCd>
        </USAddress>
        <ShortExplanationTxt>THE FOUNDATION HAS NO CURRENT PLAN TO DISSOLVE, BUT IN 2024 IT HAS MADE AND IT WILL CONTINUE TO MAKE SUBSTANTIAL DISTRIBUTIONS TO CHARITABLE ORGANIZATIONS IN ORDER TO ADVANCE THE FOUNDATION'S CHARITABLE PURPOSES.</ShortExplanationTxt>
        <DissolutionAmt>51278754</DissolutionAmt>
      </DissolutionInformationGrp>
    </DissolutionStmt>
    <InvestmentsGovtObligationsSch documentId="RetDoc2210400001">
      <USGovtObligationsBookVlEOYAmt>26237155</USGovtObligationsBookVlEOYAmt>
      <USGovtObligationsEOYFMVAmt>17128320</USGovtObligationsEOYFMVAmt>
      <StateLocalSecBookVlEOYAmt>0</StateLocalSecBookVlEOYAmt>
      <StateLocalSecEOYFMVAmt>0</StateLocalSecEOYFMVAmt>
    </InvestmentsGovtObligationsSch>
    <InvestmentsOtherSchedule2 documentId="RetDoc2018100001">
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>BIOVENTURES INVESTORS, LPII</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>AT COST</ListedAtCostOrFMVCd>
        <BookValueAmt>972551</BookValueAmt>
        <EOYFMVAmt>972551</EOYFMVAmt>
      </InvestmentsOtherGrp>
    </InvestmentsOtherSchedule2>
    <LiquidationExplanationStmt documentId="RetDoc2210900001">
      <ExplanationTxt>THE FOUNDATION HAS BEEN MAKING SUBSTANTIAL DISTRIBUTIONS TO CHARITY AS PART OF ITS CHARITABLE PURPOSE. THE AGGREGATE CHARITABLE DISTRIBUTIONS IN 2024 SUBSTANTIALLY EXCEEDED CONTRIBUTIONS AND NET INVESTMENT INCOME. THERE IS NO CURRENT PLAN TO LIQUIDATE THE FOUNDATION, BUT IT WILL CONTINUE TO MAKE SUBSTANTIAL CHARITABLE DISTRIBUTIONS.</ExplanationTxt>
    </LiquidationExplanationStmt>
    <LegalFeesSchedule documentId="RetDoc2002100001">
      <LegalFeesGrp>
        <CategoryTxt>SULLIVAN &amp; WORCESTER LLP</CategoryTxt>
        <LegalFeesAmt>35227</LegalFeesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>35227</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
    </LegalFeesSchedule>
    <OtherDecreasesSchedule documentId="RetDoc2049800001">
      <OtherDecreasesDetail>
        <Desc>ROUNDING</Desc>
        <Amt>1</Amt>
      </OtherDecreasesDetail>
    </OtherDecreasesSchedule>
    <OtherExpensesSchedule documentId="RetDoc2003200001">
      <OtherExpensesScheduleGrp>
        <Desc>2022 MA FORM PC FILING FEE</Desc>
        <RevenueAndExpensesPerBooksAmt>2000</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>2000</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>BIOVENTURES INVESTORS LIMITED K-1 INTEREST EXPENSE</Desc>
        <RevenueAndExpensesPerBooksAmt>27057</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>27057</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>BIOVENTURES INVESTORS LIMITED K-1 DEDUCTIONS</Desc>
        <RevenueAndExpensesPerBooksAmt>7291</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>7291</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>GMA FOUNDATIONS INC. CONSULTING FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>1974</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>1974</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>ROCKEFELLER PHILANTHROPY ADVISORS FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>262059</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>262059</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>NORTHERN TRUST FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>96523</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>96523</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>BIOVENTURES INVESTORS LIMITED K-1 FOREIGN TAX PAID</Desc>
        <RevenueAndExpensesPerBooksAmt>2397</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>2397</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <OtherIncomeSchedule2 documentId="RetDoc2001500001">
      <OtherIncomeDetail>
        <Desc>BIOVENTURES INVESTORS LP II ORDINARY BUSINESS INCOME</Desc>
        <RevenueAndExpensesPerBooksAmt>-2779</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>-2779</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>-2779</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>BIOVENTURES INVESTORS LP II DEBT-FINANCED INTEREST INCOME</Desc>
        <RevenueAndExpensesPerBooksAmt>31323</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>31323</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>31323</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>BIOVENTURES INVESTORS LP II DEBT-FINANCED DIVIDEND INCOME</Desc>
        <RevenueAndExpensesPerBooksAmt>0</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
    </OtherIncomeSchedule2>
    <SubstantialContributorsSch documentId="RetDoc2089200001">
      <SubstantialContributorDetail>
        <BusinessName>
          <BusinessNameLine1Txt>ALAN J DWORSKY IRREVOCABLE TRUST</BusinessNameLine1Txt>
        </BusinessName>
        <USAddress>
          <AddressLine1Txt>8 MERCER CIRCLE</AddressLine1Txt>
          <CityNm>CAMBRIDGE</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02138</ZIPCd>
        </USAddress>
      </SubstantialContributorDetail>
    </SubstantialContributorsSch>
    <TaxesSchedule documentId="RetDoc2002500001">
      <TaxesDetail>
        <CategoryTxt>2023 TAX PAYMENT FORM 990-PF</CategoryTxt>
        <Amt>70000</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </TaxesDetail>
      <TaxesDetail>
        <CategoryTxt>2022 FORM 990-PF FORM 2220 ESTIMATED TAX PENALTY</CategoryTxt>
        <Amt>5200</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </TaxesDetail>
    </TaxesSchedule>
  </ReturnData>
</Return>